Skip to main content

Find Clinical Trials

Home
Conditions
Tetanus

Clinical trial condition

Tetanus

Explore clinical trials studying Tetanus. Study availability and eligibility vary by location and protocol.

278 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Tetanus trial results

Completed

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

NCT00136604

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +22 more
Locations: GSK Investigational Site Bangkok, Thailand

GSK Investigational Site Khon Kaen, Thailand

GSK Investigational Site Songkhla, Thailand

View Trial Details

Completed

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

NCT00228917

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +22 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

GSK Investigational Site Bangkok, Thailand

View Trial Details

Completed

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

NCT00148941

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Little Rock, Arkansas, United States

GSK Investigational Site Antioch, California, United States

GSK Investigational Site Daly City, California, United States

GSK Investigational Site Fairfield, California, United States

View all 24 locations

View Trial Details

Completed

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

NCT01171989

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations: GSK Investigational Site Bydgoszcz, Poland

GSK Investigational Site Dębica, Poland

GSK Investigational Site Krakow, Poland

GSK Investigational Site Krakow, Poland

View Trial Details

Completed

Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers

NCT01577732

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
Locations: GSK Investigational Site Haiphong, Vietnam

View Trial Details

Completed

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

NCT02853929

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +37 more
Locations: GSK Investigational Site Carlton, Victoria, Australia

GSK Investigational Site Calgary, Alberta, Canada

GSK Investigational Site Halifax, Nova Scotia, Canada

GSK Investigational Site Montreal, Quebec, Canada

View all 29 locations

View Trial Details

Completed

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058

NCT00548171

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
Locations: GSK Investigational Site Westmead, New South Wales, Australia

View Trial Details

Completed

Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System

NCT03950986

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +19 more
Locations: Atlanta VA Medical Center Decatur, Georgia, United States

View Trial Details

Completed

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

NCT00352963

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations: GSK Investigational Site Alcorcón, Spain

GSK Investigational Site Almeira, Spain

GSK Investigational Site Badalona, Spain

GSK Investigational Site Barcelona, Spain

View all 22 locations

View Trial Details

Completed

Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.

NCT00835237

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
Locations: GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site DeLand, Florida, United States

GSK Investigational Site West Palm Beach, Florida, United States

View all 24 locations

View Trial Details